Institutional Ownership Lyell Immunopharma, Inc. (LYEL)
This table provides information about the institutional ownership of Lyell Immunopharma, Inc. (LYEL). We have compiled data on the 113 institutions that hold shares in the stock, with a total of 175 Million shares, which have been reported (via 13F filing form) to have a value of $1.66 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Mwg Management Ltd.
Washington, DC |
May 13, 2025 Q1 2025 |
20,162,332
shares
|
$191 Million
18.54% of portfolio
|
Q4 2021
Reduced 0.67%
|
|
|
Foresite Capital Management Iv, LLC
Larkspur, CA |
May 15, 2025 Q1 2025 |
16,007,999
shares
|
$152 Million
9.84% of portfolio
|
Q1 2025
Added 92.29%
|
|
|
Apoletto LTD
Washington, DC |
Nov 14, 2022 Q3 2022 |
15,093,969
shares
|
$143 Million
42.56% of portfolio
|
Q4 2021
Reduced 0.49%
|
|
|
Orland Properties LTD
Washington, DC |
May 13, 2025 Q1 2025 |
15,093,969
shares
|
$143 Million
9.84% of portfolio
|
Q4 2022
New holding
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
13,495,132
shares
|
$128 Million
0.0% of portfolio
|
Q2 2024
Reduced 2.86%
|
|
|
Decheng Capital LLC
Menlo Park, CA |
May 07, 2025 Q1 2025 |
11,909,341
shares
|
$113 Million
1.8% of portfolio
|
Q4 2024
New holding
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
9,737,729
shares
|
$92.4 Million
0.0% of portfolio
|
Q1 2025
Reduced 0.29%
|
|
|
Foresite Capital Management V, LLC
Larkspur, CA |
May 15, 2025 Q1 2025 |
8,133,047
shares
|
$77.2 Million
35.24% of portfolio
|
Q4 2024
New holding
|
|
|
Wu Xi App Tec Co., Ltd.
Shanghai, F4 |
Nov 08, 2024 Q3 2024 |
7,390,710
shares
|
$70.1 Million
53.56% of portfolio
|
Q3 2024
Reduced 3.79%
|
|
|
Ven Bio Partners LLC
San Francisco, CA |
May 15, 2025 Q1 2025 |
7,102,190
shares
|
$67.4 Million
4.1% of portfolio
|
Q4 2024
New holding
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
6,478,836
shares
|
$61.5 Million
0.0% of portfolio
|
Q1 2025
Reduced 6.25%
|
|
|
Alphabet Inc.
Mountain View, CA |
May 01, 2025 Q1 2025 |
5,865,125
shares
|
$55.7 Million
0.28% of portfolio
|
Q2 2021
New holding
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
4,506,857
shares
|
$42.8 Million
0.0% of portfolio
|
Q1 2025
Added 20.03%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
4,399,139
shares
|
$41.7 Million
0.0% of portfolio
|
Q1 2025
Added 6.33%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
3,702,440
shares
|
$35.1 Million
0.0% of portfolio
|
Q1 2025
Reduced 1.23%
|
|
|
Sc China Holding LTD
N/A, K3 |
May 13, 2025 Q1 2025 |
3,045,997
shares
|
$28.9 Million
0.09% of portfolio
|
Q3 2021
Added 25.0%
|
|
|
Almitas Capital LLC
Santa Monica, CA |
May 15, 2025 Q1 2025 |
2,482,606
shares
|
$23.6 Million
0.76% of portfolio
|
Q1 2025
Added 136.32%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 14, 2025 Q1 2025 |
1,768,500
shares
|
$16.8 Million
0.0% of portfolio
|
Q1 2025
Added 9.7%
|
|
|
Mic Capital Management Uk LLP
London, X0 |
May 15, 2025 Q1 2025 |
1,740,569
shares
|
$16.5 Million
0.26% of portfolio
|
Q3 2023
Reduced 43.13%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
1,604,676
shares
|
$15.2 Million
0.0% of portfolio
|
Q1 2025
Reduced 2.5%
|
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
1,295,073
shares
|
$12.3 Million
0.0% of portfolio
|
Q1 2025
Reduced 1.16%
|
|
|
Td Asset Management Inc
|
May 07, 2025 Q1 2025 |
1,004,642
shares
|
$9.53 Million
0.0% of portfolio
|
Q2 2024
Added 4.23%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
May 15, 2025 Q1 2025 |
876,037
shares
|
$8.31 Million
0.07% of portfolio
|
Q1 2025
Reduced 31.35%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
866,403
shares
|
$8.22 Million
0.0% of portfolio
|
Q1 2025
Reduced 28.65%
|
|
|
Johnson & Johnson
New Brunswick, NJ |
May 07, 2025 Q1 2025 |
823,317
shares
|
$7.81 Million
0.15% of portfolio
|
Q4 2024
New holding
|